Prognostic factors and natural history in lymph node-negative breast cancer patients
- 35 Downloads
The prognostic significance of clinical and histological factors as well as hormone receptors was analyzed in a population of 3,064 lymph node-negative breast cancer patients operated in the Stockholm region between 1976 and 1988. None of these patients received systemic adjuvant treatment. Multivariate analysis showed that only histological tumor size, number of examined axillary lymph nodes, and progesterone receptors were independent prognostic factors in terms of recurrence-free interval. An individual risk of recurrence was calculated taking into account these three factors to discriminate between three groups of patients with a risk of less than 15%, 15–25%, and more than 25% of recurrence at 5 years. Similar results were obtained taking into account only the first two factors. The prognostic information added by the knowledge of progesterone receptors only changed the recurrence rate in approximately 3%. This study showed that conventional prognostic factors permit the identification of high risk lymph node-negative breast cancer patients. Results obtained by the use of new more sophisticated factors should be compared with those obtained analyzing strong conventional prognostic factors.
Key wordsaxillary lymph nodes node-negative breast cancer prognosis hormone receptors progesterone receptor tumor size multivariate analysis
Unable to display preview. Download preview PDF.
- 1.Early Breast Cancer Trialists' Collaborative Group: Treatment of early breast cancer. Vol 1. Worldwide evidence 1985–1990. In: Oxford Medical Publications, 1990Google Scholar
- 6.Wrange Ö, Nordenskjöld B, Gustafsson JA: Cytosol estradiol receptor in human mammary carcinoma. An assay based on isolectric focusing in polyacrylamide gel. Anal Biochem 85: 416–421, 1978Google Scholar
- 8.UICC: TNM: Classification of malignant tumours. 3rd edition. Geneva, 1979Google Scholar
- 9.Arriagada R, Mouriesse H, Sarrazin D, Clark RM, Deboer G: Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave-Roussy Institute and The Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 11: 1751–1757, 1985PubMedGoogle Scholar
- 10.Byar DP: Analysis of survival data: Cox and Weibull models with covariates. In: Miké V, Stanley KE (eds) Statistics in Medical Research. J. Wiley, New York, 1982, pp 365–401Google Scholar
- 14.Arriagada R, Rutqvist LE, Kramar A, Johansson H: Competing risks determining event-free survival in early breast cancer. Brit J Cancer (submitted)Google Scholar
- 15.Fisher B, Redmond C, Fisher ER, Caplan R, et al.: Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 6: 1076–1087, 1988PubMedGoogle Scholar
- 24.Wilking N, Rutqvist LE, Carstensen J, Mattsson A, Skoog L, et al.: Prognosis significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncologica (in press)Google Scholar
- 26.Fisher B, Slack NH: Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet 130: 79–88, 1970Google Scholar
- 36.Spyratos F, Maudelonede T, Brouillet JP: Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet ii: 1115–1118, 1989Google Scholar
- 38.Rutqvist LE, Miller AB, Andersson I, Hakama M, Hakulinen T, Sigfusson BF, Tabar L: Reduced breast-cancer mortality with mammography screening. An assessment of currently available data. Int J Cancer 5: 76–84, 1990Google Scholar